ParkerVision registers 5.87M shares for resale
ParkerVision, Inc. files a Prospectus Supplement registering 5,871,584 shares of Common Stock for resale by selling stockholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ParkerVision, Inc. files a Prospectus Supplement registering 5,871,584 shares of Common Stock for resale by selling stockholders. The supplement attaches a Form 8-K reporting that on April 22, 2026 the Compensation Committee extended the expiration dates of previously granted, fully vested nonqualified stock options held by CEO Jeffrey Parker (2,660,000 options) and CFO Cynthia French (870,550 options) from August 7, 2026 to August 7, 2029 with no change to exercise price ($0.171) or share counts. The company expects to record a one-time non-cash share-based compensation charge of approximately $360,000 related to the modification. The resale proceeds will not be received by the company.
Insights
Extension preserves option life but creates a modest non-cash charge.
The Committee extended the expiration dates on fully vested nonqualified options for the CEO and CFO, keeping the exercise price ($0.171) and share counts unchanged. That preserves the awards' remaining time value without issuing new shares.
The company will record a one-time non-cash share-based compensation charge of $360,000. The economic effect is accounting-level; cash flow is unaffected at modification.
Prospectus supplement registers 5.87M resale shares; issuer receives no proceeds.
The supplement updates a prior prospectus to register resale of 5,871,584 shares issued under earlier purchase agreements. The filing states explicitly that the company will not receive proceeds from sales by the selling stockholders.
Plan mechanics and selling holder identities are in the underlying prospectus; timing and distribution methods are governed by that prospectus and the attached 8-K.
Key Figures
Key Terms
Prospectus Supplement regulatory
Selling stockholders financial
Nonqualified stock options compensation
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does ParkerVision's Prospectus Supplement register (PRKR)?
Which executives had their options modified at ParkerVision (PRKR)?
What is the exercise price and new expiration date for the modified options?
Will ParkerVision record an accounting charge for the option modifications?
Does ParkerVision receive proceeds from the registered resale (PRKR)?
AI-generated analysis. How Rhea-AI works. Not financial advice.